Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9337 - 9344 of 12089 results

USCIS Resumes Premium Processing for H-1B Extensions
July 13, 2015| Alert| Viewpoint

Privacy Monday - July 13, 2015
July 13, 2015| Blog| Viewpoint

Delivery System Reform 2.0: Scaling Alternative Payment Models is the New Normal
July 13, 2015| Blog| Viewpoint

FCC Modifies Cost Recovery Rules for Medical Device Tests and Proposes Greater Access to MedRadio Bands for Testing
July 13, 2015| Advisory| Viewpoint

GMOs in the Hotseat: White House to Overhaul Regulatory Framework on Biotechnology
July 10, 2015| Blog| Viewpoint

DOL Questions About Duties Tests Should Concern Employers (SHRM)
July 10, 2015| Blog| Viewpoint

Corporate Divorce: No Fault Employment?
July 9, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
